Updated:
Dongwha Pharmaceutical
Dongwha Pharmaceutical traces its founding to 1897 in Seoul. Yoon Do-joon established the company and remains Chairman. Yoon In-ho, fourth-generation family...
Dongwha Pharmaceutical
Dongwha Pharmaceutical traces its founding to 1897 in Seoul. Yoon Do-joon established the company and remains Chairman. Yoon In-ho, fourth-generation family member, holds the roles of President and CEO of Dongwha Pharm and CEO of DWP Holdings. The company produces antibiotics and over-the-counter medicines. It also manufactures cosmetic products and health supplements. Operations center on pharmaceutical manufacturing and healthcare product lines. Geographic focus remains South Korea with facilities in Seoul, Chungju and Yongin. Yoon Hyun-kyung serves as Vice President. The Bu Chae Pyo Gha Song Foundation operates as the associated philanthropic vehicle. No recent operational events from the last 24 months appear in available records. DWP Holdings functions as the primary affiliate holding company. This structure separates operating pharmaceutical activities from family investment vehicles.
General information
Firm type
Corporate Investor
Year founded
1897
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Principals
Yoon Do-joon
Chairman
Yoon In-ho
President and CEO
Yoon Hyun-kyung
Vice President
Sector focus
Frequently asked questions
Who runs investment decisions at Dongwha Pharmaceutical?
Yoon In-ho serves as President and CEO. Yoon Do-joon remains Chairman. Yoon Hyun-kyung holds the Vice President title.
How is Dongwha Pharmaceutical related to DWP Holdings?
DWP Holdings acts as the affiliate holding company. It supports family and business investments alongside the core pharmaceutical operations.
Does Dongwha Pharmaceutical maintain philanthropic structures?
The Bu Chae Pyo Gha Song Foundation operates as the associated philanthropic vehicle. Yoon Do-joon serves as its President.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: